390 related articles for article (PubMed ID: 29142285)
1. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.
Mehrpouya-Bahrami P; Chitrala KN; Ganewatta MS; Tang C; Murphy EA; Enos RT; Velazquez KT; McCellan J; Nagarkatti M; Nagarkatti P
Sci Rep; 2017 Nov; 7(1):15645. PubMed ID: 29142285
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity.
Mehrpouya-Bahrami P; Miranda K; Singh NP; Zumbrun EE; Nagarkatti M; Nagarkatti PS
J Biol Chem; 2019 May; 294(19):7669-7681. PubMed ID: 30910812
[TBL] [Abstract][Full Text] [Related]
3. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.
Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W
FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity.
Wei LW; Yuan ZQ; Zhao MD; Gu CW; Han JH; Fu L
Biochemistry (Mosc); 2018 Oct; 83(10):1279-1287. PubMed ID: 30472964
[TBL] [Abstract][Full Text] [Related]
5. Peripheral cannabinoid 1 receptor blockade mitigates adipose tissue inflammation via NLRP3 inflammasome in mouse models of obesity.
Han JH; Shin H; Rho JG; Kim JE; Son DH; Yoon J; Lee YJ; Park JH; Song BJ; Choi CS; Yoon SG; Kim IY; Lee EK; Seong JK; Kim KW; Kim W
Diabetes Obes Metab; 2018 Sep; 20(9):2179-2189. PubMed ID: 29740969
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance.
Grunewald ZI; Lee S; Kirkland R; Ross M; de La Serre CB
Physiol Behav; 2019 Feb; 199():282-291. PubMed ID: 30502357
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system links gut microbiota to adipogenesis.
Muccioli GG; Naslain D; Bäckhed F; Reigstad CS; Lambert DM; Delzenne NM; Cani PD
Mol Syst Biol; 2010 Jul; 6():392. PubMed ID: 20664638
[TBL] [Abstract][Full Text] [Related]
8. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease.
Jorgačević B; Vučević D; Vesković M; Mladenović D; Vukićević D; Vukićević RJ; Todorović V; Radosavljević T
Can J Physiol Pharmacol; 2019 Feb; 97(2):120-129. PubMed ID: 30673308
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells.
Miranda K; Mehrpouya-Bahrami P; Nagarkatti PS; Nagarkatti M
Front Immunol; 2019; 10():1049. PubMed ID: 31134094
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
mBio; 2017 May; 8(3):. PubMed ID: 28536285
[TBL] [Abstract][Full Text] [Related]
11. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
Miranville A; Herling AW; Biemer-Daub G; Voss MD
Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
[TBL] [Abstract][Full Text] [Related]
12. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
[TBL] [Abstract][Full Text] [Related]
13. A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
Hsiao WC; Shia KS; Wang YT; Yeh YN; Chang CP; Lin Y; Chen PH; Wu CH; Chao YS; Hung MS
Diabetes Obes Metab; 2015 May; 17(5):495-504. PubMed ID: 25656402
[TBL] [Abstract][Full Text] [Related]
14. CB
O'Keefe L; Vu T; Simcocks AC; Jenkin KA; Mathai ML; Hryciw DH; Hutchinson DS; McAinch AJ
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232744
[TBL] [Abstract][Full Text] [Related]
15. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice.
Schneeberger M; Everard A; Gómez-Valadés AG; Matamoros S; Ramírez S; Delzenne NM; Gomis R; Claret M; Cani PD
Sci Rep; 2015 Nov; 5():16643. PubMed ID: 26563823
[TBL] [Abstract][Full Text] [Related]
16. Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats.
Chen W; Chen Z; Xue N; Zheng Z; Li S; Wang L
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):721-32. PubMed ID: 23620336
[TBL] [Abstract][Full Text] [Related]
17. Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity.
Jiang T; Gao X; Wu C; Tian F; Lei Q; Bi J; Xie B; Wang HY; Chen S; Wang X
Nutrients; 2016 Feb; 8(3):126. PubMed ID: 26938554
[TBL] [Abstract][Full Text] [Related]
18. CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction.
Lipina C; Vaanholt LM; Davidova A; Mitchell SE; Storey-Gordon E; Hambly C; Irving AJ; Speakman JR; Hundal HS
Aging Cell; 2016 Apr; 15(2):325-35. PubMed ID: 26757949
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of cannabinoid CB
Udi S; Hinden L; Ahmad M; Drori A; Iyer MR; Cinar R; Herman-Edelstein M; Tam J
Br J Pharmacol; 2020 Jan; 177(1):110-127. PubMed ID: 31454063
[TBL] [Abstract][Full Text] [Related]
20. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice.
Jourdan T; Djaouti L; Demizieux L; Gresti J; Vergès B; Degrace P
Diabetes; 2010 Apr; 59(4):926-34. PubMed ID: 20110567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
